Pancreatic Necrosis and Pancreatic Abscess Workup
- Author: Abraham Mathew, MD, MS; Chief Editor: BS Anand, MD more...
No specific hematologic studies define infected necrosis or pancreatic abscess. A persistently elevated white blood cell count with a left shift and positive blood cultures is suggestive of this diagnosis.
The degree of pancreatic enzyme elevation does not directly indicate the degree of necrosis.
The presence of air in necrotic tissue in a pseudocyst on imaging studies is specific for infection. The absence of a communication to the gut (often by spontenous drainage into the gut lumen) is also a sign of infection.
Abdominal computed tomography (CT) scanning with intravenous (IV) contrast; ultrasonography, either endoscopic or transabdominal; and magnetic resonance imaging (MRI) (with gadolinium) are potential modes for imaging pancreatic necrosis or abscess.
MRI is becoming the imaging study of choice due to concerns regarding the use of iodinated contrast, which is said, by some, to devitalize marginal tissue, increasing the burden of necrotic tissue.
Computed Tomography Scanning and Magnetic Resonance Imaging
The current criterion standard for initial evaluation is contrast-enhanced CT scan (see the following image), which may reveal ischemic pancreatic tissue as evidenced by the lack of uptake of contrast. There is some suggestion that early CT scan may be detrimental in ANP, with IV contrast worsening ischemia.
Consider repeat imaging in all patients with ANP who develop worsening abdominal pain, develop signs or symptoms of obstruction, or have a prolonged clinical course.
MRI may be of some additional benefit in the acute evaluation of ANP; gadolinium does not cause a worsening of ischemia in experimental models.
Splenic vein thrombosis is seen in 40% of patients with WOPN.
Pancreatic necrosis appears as devitalized tissue with decreased IV contrast present on CT scan or MRI. A pancreatic pseudocyst has a rim of fibrous tissue surrounding a pocket of peripancreatic fluid.
Earlier accumulations of fluid without the fibrous capsule, or peripancreatic fluid collections, and the surrounding inflammatory tissue were referred to as a phlegmon, but this term is now obselete.
Demonstrable necrotic tissue in the pseudocyst may exist. Typically, this develops more than 3 weeks after the initial bout of pancreatitis.
In the absence of cholangitis or jaundice, the 2013 American College of Gastroenterology (ACG) guidelines recommend magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasonography, rather than diagnostic endoscopic retrograde cholangiopancreatography (ERCP) to screen for choledocholithiasis as the suspected etiology of acute pancreatitis.
EUS-guided transgastric drainage of a pancreatic abscess, with insertion of 2 double-pigtail catheters has also been reported to be useful.
Endoscopic necrosectomy and draining may give impressive and immediate symptom relief.[6, 9]
No randomized trials have evaluated the minimally invasive techniques for infected pancreatic necrosis, and not all guidelines from professional organizations show "consensus to recommend this minimally invasive management of pancreatic abscess."[10, 11]
This lack of agreement likely relates to the fact that successful treatment of symptomatic, sterile or infected walled-off pancreatic necrosis with transoral/transmural endoscopic drainage needs to be followed by percutaneous drainage in 40% or by operative interventions in 20%.[12, 13, 14]
In cases of WOPN, creating multiple gateways for drainage of necrotic debris improves treatment success.
Endoscopic drainage of pancreatic fluid collections in persons with acute or chronic pancreatitis is an accepted alternative treatment option to surgical intervention; it provides a successful drainage of the fluid and relief of symptoms in almost 90% of patients. Complications occur in 11% of patients, including death in 5%. Not removing the transmural stents decreases the recurrence of pancreatic fluid collection.
In persons with SAP having intervention for infected reasons of infection or abscess, 20% will develop an external pancreatic fistula (EPF).
Spontaneous closure of the EPF occurs in 88% of persons in a median of 70 days. Of these 88% whose EPF closes, approximately 24% develop a pancreatic pseudocyst requiring surgical management.
CT-guided or ultrasonography-guided needle aspiration
The presence of either bacterial or fungal flora in pancreatic fluid collections usually aspirated via CT-guided needle biopsy is the sine qua non of pancreatic abscess. The presence of organisms on either Gram stain or culture is essential to establish a diagnosis of abscess.
The presence of either bacterial or fungal microbiota in pancreatic fluid collections (usually aspirated via CT-guided needle biopsy) is essential to establish a diagnosis of pancreatic abscess.
Pancreatic fluid collections are frequent sequelae of pancreatitis, and endoscopic drainage of these collections is gaining acceptance as an alternative to surgical drainage. Endoscopic ultrasound (EUS)-guided drainage should be reserved for prepancreatic fluid collections located at the pancreatic tail. These fluid collections should be evaluated by EUS before attempts at endoscopic drainage.
In the last two decades, the indications for surgery have become less aggressive, focusing more on the treatment of complications such as necrosis, abscess, and pseudocyst.
Even with aggressive intravenous fluid replacement, nutritional support and early intervention of pancreatic necrosis or abscess, the hospital mortality rate of SAP is about 20%.
Sterile necrosis may be followed with serial CT-guided drainage and continued antibiotics.
Surgical drainage of infected necrosis or an abscess is the procedure for cure. Placement of indwelling drains after the initial procedure may be necessary for complete resolution.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan. 62(1):102-11. [Medline].
Gukovsky I, Pandol SJ, Mareninova OA, Shalbueva N, Jia W, Gukovskaya AS. Impaired autophagy and organellar dysfunction in pancreatitis. J Gastroenterol Hepatol. 2012 Mar. 27 Suppl 2:27-32. [Medline]. [Full Text].
Pitchumoni CS, Patel NM, Shah P. Factors influencing mortality in acute pancreatitis: can we alter them?. J Clin Gastroenterol. 2005 Oct. 39(9):798-814. [Medline].
Dugernier T, Dewaele J, Laterre PF. Current surgical management of acute pancreatitis. Acta Chir Belg. 2006 Mar-Apr. 106(2):165-71. [Medline].
Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010 Sep. 139(3):813-20. [Medline].
Seewald S, Ang TL, Richter H, Teng KY, Zhong Y, Groth S, et al. Long-term results after endoscopic drainage and necrosectomy of symptomatic pancreatic fluid collections. Dig Endosc. 2012 Jan. 24(1):36-41. [Medline].
Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Sep. 108(9):1400-15; 1416. [Medline].
Ciesek S, Manns MP, Kruger M. [Retroperitoneal abscess in a man with severe necrotizing pancreatitis]. Dtsch Med Wochenschr. 2006 Sep 8. 131(36):1937-40. [Medline].
Mathew A, Biswas A, Meitz KP. Endoscopic necrosectomy as primary treatment for infected peripancreatic fluid collections (with video). Gastrointest Endosc. 2008 Oct. 68(4):776-82. [Medline].
Loveday BP, Mittal A, Phillips A, Windsor JA. Minimally invasive management of pancreatic abscess, pseudocyst, and necrosis: a systematic review of current guidelines. World J Surg. 2008 Nov. 32(11):2383-94. [Medline].
Bucher P, Pugin F, Morel P. Minimally invasive necrosectomy for infected necrotizing pancreatitis. Pancreas. 2008 Mar. 36(2):113-9. [Medline].
Papachristou GI, Takahashi N, Chahal P, Sarr MG, Baron TH. Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg. 2007 Jun. 245(6):943-51. [Medline].
Chen J, Fukami N, Li Z. Endoscopic approach to pancreatic pseudocyst, abscess and necrosis: Review on recent progress. Dig Endosc. 2012 Sep. 24(5):299-308. [Medline].
Loveday BP, Rossaak JI, Mittal A, Phillips A, Windsor JA. Survey of trends in minimally invasive intervention for necrotizing pancreatitis. ANZ J Surg. 2011 Jan. 81(1-2):56-64. [Medline].
Bang JY, Wilcox CM, Trevino J, Ramesh J, Peter S, Hasan M, et al. Factors impacting treatment outcomes in the endoscopic management of walled-off pancreatic necrosis. J Gastroenterol Hepatol. 2013 Nov. 28(11):1725-32. [Medline]. [Full Text].
Hookey LC, Debroux S, Delhaye M, Arvanitakis M, Le Moine O, Deviere J. Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc. 2006 Apr. 63(4):635-43. [Medline].
Sikora SS, Khare R, Srikanth G, Kumar A, Saxena R, Kapoor VK. External pancreatic fistula as a sequel to management of acute severe necrotizing pancreatitis. Dig Surg. 2005. 22(6):446-51; discussion 452. [Medline].
Will U, Wanzar C, Gerlach R, Meyer F. Interventional ultrasound-guided procedures in pancreatic pseudocysts, abscesses and infected necroses - treatment algorithm in a large single-center study. Ultraschall Med. 2011 Apr. 32(2):176-83. [Medline].
Bakker OJ, van Santvoort HC, van Brunschot S, et al, for the Dutch Pancreatitis Study Group. Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. JAMA. 2012 Mar 14. 307(10):1053-61. [Medline].